Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
17%
Ph phase_1
1
17%
Ph phase_2
4
67%

Phase Distribution

1

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
4(66.7%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 24 (66.7%)
Phase 31 (16.7%)

Trials by Status

completed350%
not_yet_recruiting117%
unknown233%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_3

Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity

NCT07528027
completedphase_2

Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes

NCT06415214
completedphase_2

Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

NCT06393348
completedphase_2

Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

NCT06671821
unknownphase_2

A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus

NCT05759897
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07528027Phase 3

Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity

Not Yet Recruiting
NCT06415214Phase 2

Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes

Completed
NCT06393348Phase 2

Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

Completed
NCT06671821Phase 2

Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

Completed
NCT05759897Phase 2

A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus

Unknown
NCT05347758Phase 1

A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy Subjects

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6